Compare Hinge Health Inc. Class A Common Stock (HNGE) vs Targa Resources Inc. Common Stock (TRGP) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Hinge Health Inc. Class A Common Stock vs Targa Resources Inc. Common Stock — how do they compare? Hinge Health Inc. Class A Common Stock trades at $104.95 (market cap $8.48B), while Targa Resources Inc. Common Stock trades at $290.9 (market cap $62.84B). The key difference: Targa Resources Inc. Common Stock is far larger — about 7.4× Hinge Health Inc. Class A Common Stock's market cap, and Targa Resources Inc. Common Stock pays a 1.71% dividend while Hinge Health Inc. Class A Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Hinge Health Inc. Class A Common Stock for 0 Days and Targa Resources Inc. Common Stock for 5 Days on average.
| HNGE | TRGP | |
|---|---|---|
Market Cap | $8.48B | $62.84B |
Volume | 879,799 | 654,800 |
Sector | Health | Energy |
52-Week High | $105.14 | $302.25 |
52-Week Low | $31.17 | $146.30 |
Typical Hold Time | 0 Days | 5 Days |
Enterprise Value | $8.10B | $82.28B |
Dividend Yield | — | 1.71% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Hinge Health (HNGE) trades at $105.14, up 0.31% on the day and near its 52-week high. The stock shows strong analyst support with a 93.75% buy rating, though the current price exceeds the consensus target of $101.62. Recent earnings beat expectations in two of the last three quarters, with Q3 2026 results due November 2. Fundamentals indicate robust revenue growth projections from $588 million in 2025 to $720 million in 2026, alongside a shift to profitability, but valuation multiples like EV/EBITDA at 82.33 remain elevated.
The outlook is cautiously optimistic given projected profitability and expansion into migraine and GI care, but risks include high insider selling, competitive pressures, and the stock's premium valuation. Execution on growth targets and Q3 earnings will be critical for sustaining momentum.
TRGP trades at $293.04, up 0.86% today, with a bullish technical signal driven by moving averages and a consensus analyst price target of $329.54. The company reported strong Q2 2026 EPS of $3.54, beating expectations, and maintains robust profitability with a net income margin of 13.54% and ROE of 72.27%. Recent news highlights a $1.25 quarterly dividend and sustainability reporting, reflecting stable operations.
The outlook is positive given earnings beats, high analyst buy ratings (82%), and projected revenue growth, though risks include commodity price exposure and high debt-to-asset ratio of 68.07%. The stock's current price near the analyst low target of $294.00 suggests potential upside if fundamentals hold.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Hinge Health Inc. Class A Common Stock
Hinge Health Inc. operates a digital musculoskeletal (MSK) care platform that delivers exercise therapy for joint and muscle conditions through health plans and employers. Its Precision Motion Technology combines wearable sensors and computer vision to guide patients through clinician-directed physical therapy remotely.
Read more on HNGE →About Targa Resources Inc. Common Stock
Targa Resources provides midstream infrastructure for natural gas and natural gas liquids. Its services include gathering, processing, transportation, fractionation, storage, and export logistics.
Read more on TRGP →
